Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit

M. Neill, M. Kinnear, C. Souter, F. Reid

Research output: Contribution to conferenceProceeding

Abstract

Cardiovascular disease can manifest as coronary heart disease (CHD) or stroke and is a significant cause of morbidity and mortality in Scotland. The long term secondary preventative management of CHD is evidence based and despite a wide range of guidelines available evidence suggests there is a lack of adherence to lifestyle recommendations and the use of prophylactic medication in patients with CHD. Improvements in management of acute coronary syndrome (ACS) have led to short hospital admissions and limited time to titrate new medicines to evidence based doses during hospital stay. There is a need for good communication between secondary and primary care to ensure evidence based practice in secondary prevention of ACS. This study investigated one method of communication with the aim to improve pharmaceutical care between primary and secondary care for secondary prevention of ACS.
Original languageEnglish
Pages57
Number of pages1
Publication statusPublished - 17 May 2013
EventUKCPA/GHP conference May 2013 - , United Kingdom
Duration: 11 May 2013 → …

Conference

ConferenceUKCPA/GHP conference May 2013
CountryUnited Kingdom
Period11/05/13 → …

Fingerprint

Pharmaceutical Services
Acute Coronary Syndrome
Cardiology
Coronary Disease
Secondary Care
Secondary Prevention
Primary Health Care
Communication
Evidence-Based Practice
Evidence-Based Medicine
Scotland
Life Style
Length of Stay
Cardiovascular Diseases
Stroke
Guidelines
Morbidity
Mortality

Keywords

  • pharmaceutical care
  • acute coronary syndrome
  • prophylactic medication

Cite this

Neill, M., Kinnear, M., Souter, C., & Reid, F. (2013). Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit. 57. UKCPA/GHP conference May 2013, United Kingdom.
Neill, M. ; Kinnear, M. ; Souter, C. ; Reid, F. / Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit. UKCPA/GHP conference May 2013, United Kingdom.1 p.
@conference{f1b7e79a640047aa81cdeb290be0f75a,
title = "Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit",
abstract = "Cardiovascular disease can manifest as coronary heart disease (CHD) or stroke and is a significant cause of morbidity and mortality in Scotland. The long term secondary preventative management of CHD is evidence based and despite a wide range of guidelines available evidence suggests there is a lack of adherence to lifestyle recommendations and the use of prophylactic medication in patients with CHD. Improvements in management of acute coronary syndrome (ACS) have led to short hospital admissions and limited time to titrate new medicines to evidence based doses during hospital stay. There is a need for good communication between secondary and primary care to ensure evidence based practice in secondary prevention of ACS. This study investigated one method of communication with the aim to improve pharmaceutical care between primary and secondary care for secondary prevention of ACS.",
keywords = "pharmaceutical care, acute coronary syndrome, prophylactic medication",
author = "M. Neill and M. Kinnear and C. Souter and F. Reid",
year = "2013",
month = "5",
day = "17",
language = "English",
pages = "57",
note = "UKCPA/GHP conference May 2013 ; Conference date: 11-05-2013",

}

Neill, M, Kinnear, M, Souter, C & Reid, F 2013, 'Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit' UKCPA/GHP conference May 2013, United Kingdom, 11/05/13, pp. 57.

Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit. / Neill, M.; Kinnear, M.; Souter, C.; Reid, F.

2013. 57 UKCPA/GHP conference May 2013, United Kingdom.

Research output: Contribution to conferenceProceeding

TY - CONF

T1 - Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit

AU - Neill, M.

AU - Kinnear, M.

AU - Souter, C.

AU - Reid, F.

PY - 2013/5/17

Y1 - 2013/5/17

N2 - Cardiovascular disease can manifest as coronary heart disease (CHD) or stroke and is a significant cause of morbidity and mortality in Scotland. The long term secondary preventative management of CHD is evidence based and despite a wide range of guidelines available evidence suggests there is a lack of adherence to lifestyle recommendations and the use of prophylactic medication in patients with CHD. Improvements in management of acute coronary syndrome (ACS) have led to short hospital admissions and limited time to titrate new medicines to evidence based doses during hospital stay. There is a need for good communication between secondary and primary care to ensure evidence based practice in secondary prevention of ACS. This study investigated one method of communication with the aim to improve pharmaceutical care between primary and secondary care for secondary prevention of ACS.

AB - Cardiovascular disease can manifest as coronary heart disease (CHD) or stroke and is a significant cause of morbidity and mortality in Scotland. The long term secondary preventative management of CHD is evidence based and despite a wide range of guidelines available evidence suggests there is a lack of adherence to lifestyle recommendations and the use of prophylactic medication in patients with CHD. Improvements in management of acute coronary syndrome (ACS) have led to short hospital admissions and limited time to titrate new medicines to evidence based doses during hospital stay. There is a need for good communication between secondary and primary care to ensure evidence based practice in secondary prevention of ACS. This study investigated one method of communication with the aim to improve pharmaceutical care between primary and secondary care for secondary prevention of ACS.

KW - pharmaceutical care

KW - acute coronary syndrome

KW - prophylactic medication

UR - http://www.ukcpa.net/wp-content/uploads/2010/11/May-Conference-Handbook-2013-Abstracts-only.pdf

M3 - Proceeding

SP - 57

ER -

Neill M, Kinnear M, Souter C, Reid F. Optimising pharmaceutical care after acute coronary syndrome for patients discharged from the cardiology unit. 2013. UKCPA/GHP conference May 2013, United Kingdom.